EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN–DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES

Introduction/Objectives: To evaluate the efficacy and safety of elranatamab in a pooled analysis of patients (pts) enrolled in MagnetisMM trials with relapsed or refractory multiple myeloma (RRMM) who had prior exposure to B-cell maturation antigen (BCMA)-directed therapy. Materials and methods: Eli...

Повний опис

Бібліографічні деталі

Автори:	A Nooka, A Lesokhin, M Mohty, R Niesvizky, C Maisel, B Arnulf, S Larson, A Varshavsky-Yanovsky, X Leleu, L Karlin, D Vesole, N Bahlis, CF Larrea, N Raje, E Leip, U Conte, M Elmeliegy, A Viqueira, V Blunk, S Manier
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2023-10-01
Серія:	Hematology, Transfusion and Cell Therapy
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S2531137923009410
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!